Xilio Therapeutics, Inc.
Key Metrics
Market Snapshot
About
Xilio Therapeutics is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies. The company utilizes its proprietary platform to engineer cytokines and other immune-modulatory proteins that are activated in the tumor microenvironment. Xilio aims to improve the therapeutic index of cancer treatments while reducing systemic toxicity.